Literature DB >> 24960194

Host-guest interactions in Fe(III)-trimesate MOF nanoparticles loaded with doxorubicin.

Resmi Anand1, Francesco Borghi, Francesco Manoli, Ilse Manet, Valentina Agostoni, Pierluigi Reschiglian, Ruxandra Gref, Sandra Monti.   

Abstract

Doxorubicin (DOX) entrapment in porous Fe(III)-trimesate metal organic frameworks (MIL-100(Fe)) nanoparticles was investigated in neutral Tris buffer via UV-vis absorption, circular dichroism (CD), and fluorescence. The binding constants and the absolute spectra of the DOX-MIL-100(Fe) complexes were determined via absorption and fluorescence titrations. A binding model where DOX associates as monomer to the dehydrated Fe3O (OH)(H2O)2 [(C6H3)(CO2)3]2 structural unit in 1:1 stoichiometry, with apparent association constant of (1.1 to 1.8) × 10(4) M(-1), was found to reasonably fit the experimental data. Spectroscopic data indicate that DOX binding occurs via the formation of highly stable coordination bonds between one or both deprotonated hydroxyl groups of the aglycone moiety and coordinatively unsaturated Fe(III) centers. Complete quenching of the DOX fluorescence and remarkable thermal and photochemical stability were observed for DOX incorporated in the MIL-100(Fe) framework.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24960194     DOI: 10.1021/jp503809w

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  10 in total

Review 1.  Metal-Organic Frameworks for Liquid Phase Applications.

Authors:  Anjaiah Nalaparaju; Jianwen Jiang
Journal:  Adv Sci (Weinh)       Date:  2021-01-21       Impact factor: 16.806

2.  N-doped carbon nanodots@UiO-66-NH2 as novel nanoparticles for releasing of the bioactive drug, rosmarinic acid and fluorescence imaging.

Authors:  Khalil Tabatabaeian; Masoomeh Simayee; Abdollah Fallah-Shojaie; Farhad Mashayekhi
Journal:  Daru       Date:  2019-06-08       Impact factor: 3.117

3.  A new cotton functionalized with iron(III) trimer-like metal framework as an effective strategy for the adsorption of triarylmethane dye: An insight into the dye adsorption processes.

Authors:  J E Conde-González; P Lorenzo-Luis; V Salvadó; J Havel; E M Peña-Méndez
Journal:  Heliyon       Date:  2021-12-04

4.  New insights into the degradation mechanism of metal-organic frameworks drug carriers.

Authors:  X Li; L Lachmanski; S Safi; S Sene; C Serre; J M Grenèche; J Zhang; R Gref
Journal:  Sci Rep       Date:  2017-10-13       Impact factor: 4.379

5.  Kinetic Analysis of the Uptake and Release of Fluorescein by Metal-Organic Framework Nanoparticles.

Authors:  Tobias Preiß; Andreas Zimpel; Stefan Wuttke; Joachim O Rädler
Journal:  Materials (Basel)       Date:  2017-02-22       Impact factor: 3.623

6.  Theranostic metal-organic framework core-shell composites for magnetic resonance imaging and drug delivery.

Authors:  Huai-Xin Zhao; Quan Zou; Shao-Kai Sun; Chunshui Yu; Xuejun Zhang; Rui-Jun Li; Yan-Yan Fu
Journal:  Chem Sci       Date:  2016-04-26       Impact factor: 9.825

Review 7.  Encapsulation, Release, and Cytotoxicity of Doxorubicin Loaded in Liposomes, Micelles, and Metal-Organic Frameworks: A Review.

Authors:  Mihad Ibrahim; Waad H Abuwatfa; Nahid S Awad; Rana Sabouni; Ghaleb A Husseini
Journal:  Pharmaceutics       Date:  2022-01-21       Impact factor: 6.321

Review 8.  Size control over metal-organic framework porous nanocrystals.

Authors:  Checkers R Marshall; Sara A Staudhammer; Carl K Brozek
Journal:  Chem Sci       Date:  2019-09-12       Impact factor: 9.825

9.  Degradation Mechanism of Porous Metal-Organic Frameworks by In Situ Atomic Force Microscopy.

Authors:  Ioanna Christodoulou; Tom Bourguignon; Xue Li; Gilles Patriarche; Christian Serre; Christian Marlière; Ruxandra Gref
Journal:  Nanomaterials (Basel)       Date:  2021-03-13       Impact factor: 5.076

Review 10.  Biomedical Applications of Metal-Organic Frameworks for Disease Diagnosis and Drug Delivery: A Review.

Authors:  Miral Al Sharabati; Rana Sabouni; Ghaleb A Husseini
Journal:  Nanomaterials (Basel)       Date:  2022-01-16       Impact factor: 5.076

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.